First-in-human Trial With Single-dose C5a-neutralizing AON-D21 in Healthy Male Subjects
Clinical trial NCT05018403 · COMPLETED
Trial details
- NCT number
- NCT05018403
- Sponsor
- Aptarion Biotech AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-03
- Primary completion
- 2022-01-05
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.